{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:55:05Z","timestamp":1761310505099,"version":"3.33.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1136\/ard.53.2.122","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis."],"prefix":"10.1016","volume":"53","author":[{"given":"P.P.","family":"Sfikakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Theocharis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Klipple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ard.51.2.286","article-title":"A brief overview of the pathogenesis of scleroderma (systemic sclerosis)","volume":"51","author":"C, LeRoy E.","year":"1992","unstructured":"LeRoy E C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992; 51: 286-8.","journal-title":"Ann Rheum Dis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0889-857X(21)01044-9","article-title":"Early immune events in scleroderma","volume":"16","author":"E, Postlethwaite A.","year":"1990","unstructured":"Postlethwaite A E. Early immune events in scleroderma. Rheum Dis Clin North Am 1990; 16: 125-9.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping and clinical correlations","volume":"27","author":"Roumm, S.D.; L, Whiteside T.; A, Medsger T.; P, Rodnan G.","year":"1984","unstructured":"Roumm SD, Whiteside T L, Medsger T A, Rodnan G P. Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping and clinical correlations. Arthritis Rheum 1984; 27: 645-53.","journal-title":"Arthritis Rheum"},{"key":"ref_4","first-page":"375","article-title":"Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy. Clin Exp Immunol","volume":"69","author":"Freundlich, B.; A, Jimenez S.","year":"1987","unstructured":"Freundlich B, Jimenez S A. Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy. Clin Exp Immunol 1987; 69: 375-84."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/anr.1780320412","article-title":"Increased proto-oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis","volume":"32","author":"Kahan, A.; Gerfaux, J.; M, Joret A.; Menkes, C.; Amor, B.","year":"1989","unstructured":"Kahan A, Gerfaux J, Joret A M, Menkes C, Amor B. Increased proto-oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis. Arthritis Rheum 1989; 32: 430-36.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","article-title":"Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis","volume":"49","author":"Gustafsson, R.; H, Totterman T.; Klareskog, L.; Hallgren, R.","year":"1990","unstructured":"Gustafsson R, Totterman T H, Klareskog L, Hallgren R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990; 49: 40-5.","journal-title":"Ann Rheum Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.1780340510","article-title":"Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis","volume":"34","author":"Hawrylko, E.; Spertus, A.; A, Mele C.; Oster, N.; Frieri, M.","year":"1991","unstructured":"Hawrylko E, Spertus A, Mele C A, Oster N, Frieri M. Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis. Arthritis Rheum 1991; 34: 580-7.","journal-title":"Arthritis Rheum"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.1780280708","article-title":"Cellular immunity to collagen and laminin in scleroderma","volume":"28","author":"E, Huffstutter J.; A, DeLustro F.; C, Leroy E.","year":"1985","unstructured":"Huffstutter J E, DeLustro F A, Leroy E C. Cellular immunity to collagen and laminin in scleroderma. Arthritis Rheum 1985; 28: 775-80.","journal-title":"Arthritis Rheum"},{"key":"ref_9","first-page":"8492","article-title":"Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: Sequence similarity with retroviral p309ga protein suggests a possible cause for autoimmunity","volume-title":"systemic sclerosis. Proc Natl Acad Sci","volume":"86","author":"G, Maul G.; A, Jimenez S.; E, Riggs; D, Ziemnicka-Kotula","year":"1989","unstructured":"Maul G G, Jimenez S A, Riggs E, Ziemnicka-Kotula D. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: Sequence similarity with retroviral p309ga protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci 1989; 86: 8492-6."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"B, Kahaleh M.; C, Leroy E.","year":"1989","unstructured":"Kahaleh M B, Leroy E C. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989; 110: 446-50.","journal-title":"Ann Intern Med"},{"key":"ref_11","first-page":"1479","article-title":"Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. Clin Invest","volume":"90","author":"E, Postlethwaite A.; A, Holness M.; H, Katai; R, Raghow","year":"1992","unstructured":"Postlethwaite A E, Holness M A, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. Clin Invest 1992; 90: 1479-85."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clin.1993.1170","article-title":"Immunohistological demonstration of transforming growth factor-b isoform expression in the skin of patients with Systemic Sclerosis","volume":"69","author":"P, Sfikakis P.; K, McCune B.; M, Tsokos; K, Aroni; G, Vayiopoulos; C, Tsokos G.","year":"1993","unstructured":"Sfikakis P P, McCune B K, Tsokos M, Aroni K, Vayiopoulos G, Tsokos G C. Immunohistological demonstration of transforming growth factor-b isoform expression in the skin of patients with Systemic Sclerosis. Clin Immunol Immunop 1993; 69: 199-204.","journal-title":"Clin Immunol Immunop"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/316369a0","article-title":"Alterations of the hprt gene in human in vivo-derived 6-thioguanine resistant T lymphocytes","volume":"316","author":"J, Albertini R.; P, O.'Neil J.; A, Nicklas J.; N, Heintz; C, Kelleher P.","year":"1985","unstructured":"Albertini R J, O'Neil J P, Nicklas J A, Heintz N, Kelleher P C. Alterations of the hprt gene in human in vivo-derived 6-thioguanine resistant T lymphocytes. Nature 1985; 316: 369-71.","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-7992(86)90013-8","article-title":"Use of T cell receptor gene probes to quantify the in vivo hprt mutations in human T lymphocytes","volume":"173","author":"A, Nicklas J.; P, O.'Neill J.; RJ, Albertini","year":"1986","unstructured":"Nicklas J A, O'Neill J P, Albertini RJ. Use of T cell receptor gene probes to quantify the in vivo hprt mutations in human T lymphocytes. Mutation Res 1986; 173: 67-72.","journal-title":"Mutation Res"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/mutage\/2.2.87","article-title":"Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans","volume":"2","author":"P, O.'Neill J.; J, McGinniss M.; K, Berman J.; M, Sullivan L.; A, Nicklas J.; J, Albertini R.","year":"1987","unstructured":"O'Neill J P, McGinniss M J, Berman J K, Sullivan L M, Nicklas J A, Albertini R J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 1987; 2: 87-94.","journal-title":"Mutagenesis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/mutage\/1.3.195","article-title":"Detection of somatic mutations in man: evaluation of the microtiter cloning assay for T-lymphocytes","volume":"1","author":"Henderson, L.; Cole, H.; Cole, J.; E, James S.; Green, M.","year":"1986","unstructured":"Henderson L, Cole H, Cole J, James S E, Green M. Detection of somatic mutations in man: evaluation of the microtiter cloning assay for T-lymphocytes. Mutagenesis 1986; 1:195-200.","journal-title":"Mutagenesis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.1689076","article-title":"T cells responsive to myelin basic protein in patients with multiple sclerosis","volume":"247","author":"Allegretta, M.; A, Nicklas J.; Sriram, S.; J, Alvertini R.","year":"1990","unstructured":"Allegretta M, Nicklas J A, Sriram S, Alvertini R J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247: 718-21.","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.175.1.297","article-title":"Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus","volume":"175","author":"Gmelig-Meylig, F.; S, Dawisha F.; D, Steinberg A.","year":"1992","unstructured":"Gmelig-Meylig F, Dawisha F S, Steinberg A D. Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J Exp Med 1992; 175: 297-300.","journal-title":"J Exp Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0027-5107(85)90051-X","article-title":"vivo mutant frequency rises among breast cancer patients after exposure to high doses of irradiation","volume":"152","author":"Messing, K.","year":"1985","unstructured":"Messing K, Bradley W E C. In vivo mutant frequency rises among breast cancer patients after exposure to high doses of irradiation. Mutation Res 1985; 152: 107-12.","journal-title":"Mutation Res"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.","journal-title":"Arthritis Rheum"},{"key":"ref_21","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"C, LeRoy E.; C, Black; R, Fleishmajer","year":"1988","unstructured":"LeRoy E C, Black C, Fleishmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. JRheumatol 1988; 15: 202-5.","journal-title":"JRheumatol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780350615","article-title":"Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis","volume":"35","author":"V, Kantor T.; L, Whiteside T.; D, Friberg; B, Buckingham R.; A, Medsger T.","year":"1992","unstructured":"Kantor T V, Whiteside T L, Friberg D, Buckingham R B, Medsger T A. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 694-9.","journal-title":"Arthritis Rheum"},{"key":"ref_23","first-page":"1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies","volume":"126","author":"Taswell, C.","year":"1981","unstructured":"Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. _Immunol 1981; 126: 1614-19.","journal-title":"_Immunol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0092-8674(90)90805-O","article-title":"The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus","volume":"61","author":"G, Standton D.; L, Dustin M.; P, Erickson H.; A, Springer T.","year":"1990","unstructured":"Standton D G, Dustin M L, Erickson H P, Springer T A. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61: 243-4.","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble Interleukin-2 receptor: Biology, function, and clinical application","volume":"113","author":"Rubin, L.A.; L, Nelson D.","year":"1990","unstructured":"Rubin LA, Nelson D L. The soluble Interleukin-2 receptor: Biology, function, and clinical application. Ann Intern Med 1990; 113: 619-27.","journal-title":"Ann Intern Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00002281-199112000-00009","article-title":"Immunologic aspects of scleroderma","volume":"3","author":"H, Korn J.","year":"1991","unstructured":"Korn J H. Immunologic aspects of scleroderma. Cur Opin Rheumatol 1991; 3: 947-52.","journal-title":"Cur Opin Rheumatol"},{"key":"ref_27","first-page":"139","article-title":"Soluble immunologic products in Scleroderma sera. Clin Immunol Immunpathol","volume":"58","author":"Kahaleh, B.","year":"1991","unstructured":"Kahaleh B. Soluble immunologic products in Scleroderma sera. Clin Immunol Immunpathol 1991; 58: 139-44."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/art.1780330310","article-title":"Soluble interleukin-2 receptors in patients with Systemic sclerosis. Clinical and laboratory correlations","volume":"33","author":"Degiannis, D.; R, Seibold J.; Czamecki, M.; Roskova, J.; Raska, K.","year":"1990","unstructured":"Degiannis D, Seibold J R, Czamecki M, Roskova J, Raska K. Soluble interleukin-2 receptors in patients with Systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum 1990; 33: 375-80.","journal-title":"Arthritis Rheum"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/clin.1993.1100","article-title":"Circulating intercellular adhesion molecule 1 in patients with Systemic Sclerosis","volume":"68","author":"P, Sfikakis P.; J, Tesar; H, Baraf; R, Lipnick; L, Klipple G.; C, Tsokos G.","year":"1993","unstructured":"Sfikakis P P, Tesar J, Baraf H, Lipnick R, Klipple G L, Tsokos G C. Circulating intercellular adhesion molecule 1 in patients with Systemic Sclerosis. Clin Immunol Immunopathol 1993; 68: 88-92.","journal-title":"Clin Immunol Immunopathol"},{"key":"ref_30","first-page":"944","article-title":"cell receptor V, B repertoire of double-negative a\/, B T cells in patients with systemic sclerosis","volume":"35","author":"Sakamoto, A.; Sumida, T.; Maeda, T.","year":"1992","unstructured":"Sakamoto A, Sumida T, Maeda T, et al. T cell receptor V,B repertoire of double-negative a\/,B T cells in patients with systemic sclerosis. Arthritis Rheu,n 1992; 35: 944-8."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5699(91)90094-A","article-title":"The distinctive specificity of antigenspecific suppressor T cells","volume":"12","author":"Sercarz, E.; Krzych, U.","year":"1991","unstructured":"Sercarz E, Krzych U. The distinctive specificity of antigenspecific suppressor T cells. Immunol Today 1991; 12: 111-8.","journal-title":"Immunol Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-065X.1990.tb00802.x","article-title":"Function of autoreactive T cells in immune responses","volume":"116","author":"Finnegan, A.; W, Needleman B.; J, Hodes R.","year":"1990","unstructured":"Finnegan A, Needleman B W, Hodes R J. Function of autoreactive T cells in immune responses. Immunol Rev 1990; 116: 15-31.","journal-title":"Immunol Rev"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.171.3.801","article-title":"Naive and memory T cells show distinct pathways of lymphocyte recirculation","volume":"171","author":"R, Mackay C.; L, Marston W.; L, Dudler","year":"1990","unstructured":"Mackay C R, Marston W L, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990; 171: 801-7.","journal-title":"J Exp Med"},{"key":"ref_34","first-page":"336","article-title":"Differential interleukin secretion by in vitro activated human CD45RA+ and CD45RO+CD4+ T cell subsets","volume":"141","author":"M, Ferrer J.; A, Pleza; M, Kreisler; F, Diaz-Espada","year":"1992","unstructured":"Ferrer J M, Pleza A, Kreisler M, Diaz-Espada F. Differential interleukin secretion by in vitro activated human CD45RA+ and CD45RO+CD4+ T cell subsets. Cell Immunol 1992; 141: 336-9.","journal-title":"Cell Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724406249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724406249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.53.2.122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:42:51Z","timestamp":1737546171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724406249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["S0003496724406249"],"URL":"https:\/\/doi.org\/10.1136\/ard.53.2.122","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1994,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.53.2.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1994 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}